This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
Europe's premier partnering event
Save the date for next yearNovember 3–5, 2025 | Vienna, Austria

Algen Biotechnologies

Profile

Algen is a platform therapeutics and drug discovery company using the world’s leading CRISPR and AI to uncover disease-driving RNA messages to find treatments for cancer, inflammation and other diseases. Spun out from Nobel Laureate Professor Jennifer Doudna's Lab, Algen aims to develop the world’s smartest drug discovery decision platform and data universe to create next-generation therapeutics. Algen has its internal drug development pipeline and partners with a number of leading pharmaceutical companies on its flagship next-generation CRISPR-based platform.